Foreign Affairs Minister Mario Lopez
affirmed that several laboratories around the world are interested in performing clinical trials for a possible COVID-19 vaccine in Peru, which would ensure availability of doses to immunize the population.
Lopez explained that Peru is coordinating with different institutions —both public and private— to ensure timely access to a vaccine
, considering that several laboratories have already entered Phase 3 of their clinical trials in human beings.
"We are working specifically with laboratories in China and the United States, as well as with other countries, in order to participate in the vaccine clinical trials," the government official said in remarks to TV Peru.
"And by clinical trials, I mean the vaccine development process itself. In this sense, Peru is a country that attracts the interest of laboratories in conducting trials throughout the national territory," he added.
Lopez noted that Peru has a geographic, racial diversity and biodiversity capabilities
, so the country meets various requirements needed to perform this clinical testing.
"That ensures availability of vaccines for the Peruvian population, but that is not all, we are taking part in some multi-stakeholder mechanisms where the World Health Organization (WHO), the Pan American Health Organization (PAHO) and laboratories participate," he stated.